Italia

¡Bienvenido/a! En esta página encontrarás las últimas noticias legales, publicaciones y eventos en Italia. Para mantenerte al corriente de las últimas novedades, guarda esta página en tu teléfono móvil o regístrate para recibir alertas electrónicas.

CMS es clave en Italia: para obtener más información, haga clic aquí.

Artículos Recientes

  •  
    27/05/2024
    Europe

    Vital Signs Spring 2024

    As we push on into 2024 and towards summer, both the weather and some legal areas are hotting up. This edition of Vital Signs looks in detail at recent developments in four diverse legal areas. First, we review the current risks and trends in commercial contracts in the life science sector. Second, we consider how the law on supplementary protection certificates (SPCs) is developing, including the status of the EU pharma law package, CJEU referrals and national case law at the supreme court level. Third, brace yourself for an important decision in UK law on public procurement and the test for the...
    Leer más
  •  
    27/05/2024
    Europe

    MiFID/MiFIR review: ESMA publishes series of consultation papers on transparency topics

    On 21 and 23 May 2024, the European Securities and Markets Authority (“ESMA”) published three consultation papers, as part of the ongoing MiFID/MiFIR review.The revised Markets in Financial Instruments Directive and Regulation (known as MiFID III/MiFIR II) came into force on 28 March 2024. The package was finalised amid widespread industry concern at the uncertainty created by apparent misalignments between the Level 1 text of MiFIR as amended, and the Level 2 text, which is yet to be updated, as well as other issues. On 27 and 28 March 2024 respectively, the EU Commission published...
    Leer más
  •  
    24/05/2024
    Europe

    EU anti-dumping investigations for Chinese lysine and vanillin imports

    On 23 May 2024, the EU opened an anti-dumping investigation concerning EU imports of lysine originating in the People’s Republic of China, which could lead to substantial anti-dumping duties on future imports.On 24 May 2024, the EU opened another anti-dumping investigation concerning EU imports of vanillin originating in the People’s Republic of China, which could lead to substantial anti-dumping duties on future imports.Lysine investigationThe products under investigation for alleged dumping are “lysine and its esters, salts thereof, and feed additives, consisting...
    Leer más
  •  
    22/05/2024
    Europe

    The EU Gigabit Infrastructure Act: Faster, Cheaper and Simpler Rollout of High-Speed Networks

    The EU Gigabit Infrastructure Act (GIA), which is set to become law after a political agreement reached in February 2024, responds to the ever-growing need for faster, more reliable, data-intensive connectivity in Europe. The key purpose of the GIA is to replace the 2014 Broadband Cost Reduction Directive and to facilitate the rollout of very high-capacity networks (VHCN) by addressing identified roadblocks such as expensive and complex procedures for network deployment. It is part of the EU’s wider goal of deploying gigabit-capable infrastructure across the EU by 2030.Main Objectives...
    Leer más
  •  
    22/05/2024
    Italy

    Digital nomad tax insights

    The new visa for digital nomads might become a particularly interesting option for workers who may benefit from the so called “impatriate” tax regime following their relocation to Italy. The Decree of February 29, 2024, in force since April 5th, has established the entry and residence permit issuance procedures for "digital nomads" and "remote workers".The provisions apply to non-EU citizens who perform highly skilled work using technological tools that allow remote work; more specifically this definition refers to self-employed foreign workers (digital nomads) or foreign employees...
    Leer más
  •  
    21/05/2024
    EU

    Consultation of the European Commission on Vifor's commitments concerning the potential abuse of dominant position due to possible anticompetitive disparagement of iron medicine

    GB FR
    In response to the Preliminary Assessment stating the potential abuse of its dominant position, Vifor proposed several commitments to rectify the potential competition law infringement. The European Commission had initiated an antitrust investigation in June 2022 against Vifor to determine if it unfairly disparaged its competitor, Pharmacosmos, by spreading misleading information about the safety of its product, Monofer. Vifor Pharma, dominant in several EEA markets, faces accusations of abusing its position, potentially violating competition law. In its proposal, Vifor proposed several commitments...
    Leer más